Translational Theranostics in Glioblastoma: FAPI-46 as a Precision Medicine Tool

By afschroeder • June 5, 2026

Jeanjean P, Swaidan A, Tse C, Kwock S, Fajnorova I, Dove R, Azrour IC, Taylor S, Comin-Anduix B, Nathanson DA, Carlucci G, Calais J, Czernin J, Besserer-Offroy É, Mona CE. Translational Theranostics in Glioblastoma: FAPI-46 as a Precision Medicine Tool. J Nucl Med. 2026 Jun 4:jnumed.125.271759. doi: 10.2967/jnumed.125.271759. Epub ahead of print. PMID: 42242868.

Tags: Cardiology/Epi, Fibroblast activation protein, Glioblastoma, Immunomodulation, Publications, targeted radiopharmaceutical therapy, theranostics

Genetic Reassessment Reveals Catecholaminergic Polymorphic Ventricular Tachycardia in Sisters Initially Diagnosed With Long QT Syndrome

Zhang C, Sarkar A, Wong E, Vaseghi M, Wang JJ. Genetic Reassessment Reveals Catecholaminergic Polymorphic Ventricular Tachycardia in Sisters Initially Diagnosed With Long QT Syndrome.[...]

Adipose Tissue Plasticity, Lipoprotein Metabolism, and Cardiovascular Risk: The Emerging Role of the GLP-1 Axis

Repetti GG, Abel ED, Tontonoz P, Sallam T. Adipose Tissue Plasticity, Lipoprotein Metabolism, and Cardiovascular Risk: The Emerging Role of the GLP-1 Axis. Circ Res.[...]

From Architecture to Brain Imaging to Leader of a Major Academic Health System: John Mazziotta Talks with Johannes Czernin About an Evolving Career and Its Origins in Nuclear Medicine

Mazziotta J, Czernin J. From Architecture to Brain Imaging to Leader of a Major Academic Health System: John Mazziotta Talks with Johannes Czernin About an[...]